Feb 18, 2015 | Digital Pathology, Instruments & Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Management & Operations
Evidence is emerging that medical laboratories using the ‘daily management’ approach can outperform other labs, even those using Lean methods
Clinical laboratories and anatomic pathology groups are information-rich environments. Yet, there is irony in the fact that—in response to financial pressures and incentives to improve the quality of medical laboratory testing services—most of the nation’s clinical labs cannot tap that rich vein of information to support performance improvement goals.
Those financial pressures have shrunk lab budgets and caused price cuts to medical laboratory test prices. These two factors are behind the trend of clinical labs and pathology groups buying middleware solutions that produce real-time data feeds on all aspects of lab operations, from phlebotomy and specimen transport, to accessioning, testing, reporting, client services monitoring, and billing/collections. (more…)
Feb 16, 2015 | Digital Pathology, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Pathology
This advanced medical laboratory test looks for 95 genetic mutations associated with cancers of the blood and may provide pathologists with a new diagnostic tool
Seeking a faster time to answer when diagnosing patients with cancers of the blood, researchers and pathologists at the Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) in Boston have developed a unique clinical laboratory assay that involves multiple genes and just takes days to perform.
This high-tech genetic diagnostic test is called Rapid Heme Panel. It scans DNA in blood or bone marrow specimens. It uses powerful next-gen sequencing technology that searches for 95 genes that frequently mutate in blood cancers, according to a press release issued by DF/BWCC.
At Dana-Farber/Brigham and Women’s cancer center, this medical laboratory test is used in patients with leukemia, Myelodysplastic syndromes caused by poorly formed or dysfunctional blood cells, and myeloproliferative disorders that fill the bone marrow with abnormal blood cells. (more…)
Feb 11, 2015 | Coding, Billing, and Collections, Compliance, Legal, and Malpractice, Digital Pathology, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Pathology
This collaborative effort with microbiology labs will keep microbiologists at the forefront of infectious disease diagnostics
A partnership of San Diego-based genome sequencing company Illumina, and the French multinational, in vitro diagnostics company bioMérieux, plans to launch a next-generation sequencing (NGS) epidemiology service that will allow microbiologists to rapidly identify strains that threaten hospital inpatients and public health, according to a press release distributed by the Illumina-bioMérieux team.
Illumina-bioMérieux Service to Aid Hospital and Public Health Labs
Illumina designated sequencing laboratories with Illumina MiSeq® systems will collaborate with microbiologists working in hospital and public health laboratories to prevent, rapidly track, and contain infectious disease agents in hospitals and communities. (more…)
Feb 4, 2015 | Digital Pathology, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology
Concept is for patients to take a pill containing nanoparticles programmed to detect cancers or other disease symptoms and a wearable gadget would report their findings
Google is using the same biomarker molecules as clinical laboratories in an attempt to enable in vitro monitoring of an individual’s health status. The device is under development and represents yet one more effort by Google (NASDAQ:GOOG) to penetrate the market for consumer health services.
This futuristic project is under development by the Google X Life Sciences team. The goal is create a device that would allow patients to noninvasively self-diagnose most diseases and health conditions.
The team is led by Andrew Conrad Ph.D.. The device under development is called the NanoParticle platform. It is a tool that continuously monitors an individual’s health status from the inside and reports what it finds through a wearable, watch-like device. (more…)
Jan 28, 2015 | Digital Pathology, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Pathology, Management & Operations
Innovative device uses acoustic sound waves to gently separate circulating cancer cells from white blood cells
In many respects, the ability to separate and identify circulating tumor cells (CTCs) is one of the holy grails of cancer diagnostics. It is widely believed that a clinical laboratory test that can effectively identify CTCs would contribute to earlier detection of cancer and improved outcomes for caner patients.
Pathologists will be interested to learn about a useful new tool that can flag circulating tumor cells. Researchers say that this approach enables them to determine if a cancerous tumor is going to spread, without tagging tumor cells with harsh chemicals. This gentler alternative to current diagnostic methods involves an innovative device that uses “tilted” sound waves to sort tumor cells from white blood cells, noted a report in Headlines & Global News.
This device is about the size of a cell phone. It was developed by a team of scientists from the Pennsylvania State University (PSU), Massachusetts Institute of Technology (MIT) and Carnegie Mellon University (CMU).
Their research was funded by the National Institutes of Health (NIH) and the National Science Foundation (NSF). The research study was published by PNAS, the journal of the U.S. National Academy of Sciences, January 5, 2015. (more…)
Jan 26, 2015 | Digital Pathology, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Pathology, Management & Operations
The advent of the CRISPR/Cas9 genetic editing tool is already generating novel therapies for diseases and will create new opportunities for pathologists and medical laboratories
In just 24 months, a new gene-editing tool has become the hot topic worldwide among researchers working to understand DNA and develop ways to manipulate it for therapeutic purposes. It goes by the acronym CRISPR and it may soon become quite familiar to most pathologists and medical laboratory scientists.
CRISPR stands for clustered regularly interspaced short palindromic repeats. The gene editing platform is known as CRISPR/CAS9. (more…)
